These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7963215)

  • 1. Oral temperature changes and cognitive decline in Alzheimer patients: a possible association.
    Robinson D; Omar SJ; Quach M; Yesavage JA; Tinklenberg J
    J Am Geriatr Soc; 1994 Nov; 42(11):1218-9. PubMed ID: 7963215
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease.
    Silvestrini M; Pasqualetti P; Baruffaldi R; Bartolini M; Handouk Y; Matteis M; Moffa F; Provinciali L; Vernieri F
    Stroke; 2006 Apr; 37(4):1010-5. PubMed ID: 16497984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RCBF in Alzheimer's disease: current issues.
    Robert P; Aubin-Brunet V; Ricq O; Bonhomme P
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():186A-187A. PubMed ID: 1498804
    [No Abstract]   [Full Text] [Related]  

  • 4. Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type.
    Celsis P; Agniel A; Puel M; Rascol A; Marc-Vergnes JP
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1602-12. PubMed ID: 3501801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease.
    Richiardi J; Monsch AU; Haas T; Barkhof F; Van de Ville D; Radü EW; Kressig RW; Haller S
    Neurobiol Aging; 2015 Jan; 36(1):33-41. PubMed ID: 25146454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effect of cerebrovascular atherosclerosis on cognition in Alzheimer's disease.
    Kim TW; Song IU; Jeong DS; Lee KS
    Arch Gerontol Geriatr; 2016; 63():55-8. PubMed ID: 26631627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise, cognitive function, and aging.
    Barnes JN
    Adv Physiol Educ; 2015 Jun; 39(2):55-62. PubMed ID: 26031719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability to tune out irrelevant information is impaired in AD.
    Love R
    Lancet Neurol; 2005 Nov; 4(11):702. PubMed ID: 16265795
    [No Abstract]   [Full Text] [Related]  

  • 9. Cognitive decline in Alzheimer disease: Impact of spirituality, religiosity, and QOL.
    Kaufman Y; Anaki D; Binns M; Freedman M
    Neurology; 2007 May; 68(18):1509-14. PubMed ID: 17470754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apathy and loss of insight in Alzheimer's disease: a SPECT imaging study.
    Ott BR; Noto RB; Fogel BS
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):41-6. PubMed ID: 8845700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study.
    Sakurai H; Hanyu H; Sato T; Kume K; Hirao K; Kanetaka H; Iwamoto T
    Geriatr Gerontol Int; 2013 Jan; 13(1):90-7. PubMed ID: 22672107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Education and the course of cognitive decline in Alzheimer disease.
    Wilson RS; Li Y; Aggarwal NT; Barnes LL; McCann JJ; Gilley DW; Evans DA
    Neurology; 2004 Oct; 63(7):1198-202. PubMed ID: 15477538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial.
    Maruyama M; Tomita N; Iwasaki K; Ootsuki M; Matsui T; Nemoto M; Okamura N; Higuchi M; Tsutsui M; Suzuki T; Seki T; Kaneta T; Furukawa K; Arai H
    J Am Geriatr Soc; 2006 May; 54(5):869-71. PubMed ID: 16696770
    [No Abstract]   [Full Text] [Related]  

  • 14. Asymmetry of brain metabolism and cognitive function.
    Haxby JV; Rapoport SI
    Geriatr Nurs; 1985; 6(4):200-3. PubMed ID: 3847376
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular cognitive impairment.
    Gilbert DT
    West Indian Med J; 2007 Dec; 56(6):479-80. PubMed ID: 18646488
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
    Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
    Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors.
    Cacabelos R; Caamaño J; Gómez MJ; Fernández-Novoa L; Franco-Maside A; Alvarez XA
    Ann N Y Acad Sci; 1996 Jan; 777():399-403. PubMed ID: 8624120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral temperature change and cognitive decline in Alzheimer's patients.
    Collins KJ
    J Am Geriatr Soc; 1996 Sep; 44(9):1135-6. PubMed ID: 8790252
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes.
    Ascher-Svanum H; Chen YF; Hake A; Kahle-Wrobleski K; Schuster D; Kendall D; Heine RJ
    Clin Ther; 2015 Jun; 37(6):1195-205. PubMed ID: 25676448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.